Searched for
MANKIND PHARMA HISTORY
Lupin Pharma, TPG Capital & EQT in talks to acquire Lalvani family-owned VitabioticsIndian drugmaker Lupin and private equity firms are exploring the acquisition of UK's Vitabiotics. The deal is valued at approximately one ...- Stock picks of the week: 5 stocks with consistent score improvement and return potential of more than 30% in 1 yearWith the US entering the Israel-Iran war, geopolitical uncertainty just went up a couple of notches. As we have said often, there is no poi...
- Hyundai Motor India in MSCI Global IndexHyundai India launched its initial public offering (IPO) in October, raising ₹27,870 crore, making it the largest IPO in Indian stock marke...
- 2025: A tale of two halves; ICICI Bank, Zomato among Motilal Oswal’s top 10 picksAfter a muted earnings performance in the first half of FY25, a recovery is anticipated in H2, fueled by higher rural spending, a strong we...
- Dipan Mehta sees long-term potential in Varun Beverages despite high valuationsSee, when it comes to FMCG, look at Britannia, from 2010 to 2020, what went right was expanding the distribution network and what is going ...
- Corrections are opportunities, if you enter the right sector and stocks: 5 stocks from pharma sector with an upside potential of up to 32%At a time when the Nifty and Sensex are trading with cuts in excess of 1%, talking of buying stocks may not appear quite right. But correct...
- Mankind may end up spinning out a winner in consumer brands unitThe company entered the OTC business in 2007 and it has grown to have established brands such as Manforce, HealthOK, Prega News, AcneStar, ...
- Block deals worth over Rs 10,934 crore this week. Trent, Mamaearth, Patanjali Foods among stocks with major actionNifty closed the week with 2% gains, despite significant block deals totaling Rs 10,934 crore across large, mid, and smallcap companies. Ta...
- Mankind: How Meerut brothers built India's 4th largest pharma firmMankind Pharma has announced a significant move by acquiring Bharat Serums and Vaccines Ltd for Rs 13,630 crore. The acquisition, partly fu...
- Biosimilars offering a great opportunity in growing market: Kewal HandaThe prices have really been coming down in terms of raw materials and particularly in APIs. There is a lot of stability there. China are al...
- Resilience and ambition have got us to where we are today, say Mankind’s Juneja brothersIntroducing pocket-friendly medicines in a price-sensitive market like India was a revolutionary strategy that made a big difference. "It t...
- ITC, Zomato, 2 Tata cos among top 10 largecap stocks shopped by MFs in DecemberMF holding in Zomato increased by a sharp 71 million shares month-on-month (MoM) in December, according to a report by PhillipCapital. Shar...
- Bhavin Shah continues to like regional bank, wealth management stocks. Here’s why“We have exposure to regional banks in the South. There are banks which are going through some transformation, better management and that i...
- Why Mankind has an edge over its peers? Rajeev Juneja explainsIn 95, our turnover was Rs 5 crore and every year, the thought was, whatever we are doing in one year, can we do in one month? On this phil...
- Pet foods startup Dogsee Chew raises Rs 50 crore in Series A roundDogsee Chew said it will use the funds for brand building, R&D, and building a strong distribution network.
- Cannabis startup HempStreet secures $1 million in Pre-Series A fundingBeing the first R&D to retail cannabis player in India, the company is pioneering the use of several cutting edge technological innovations...
- Experts to decide on inclusion and exclusion of antibiotics from NLEM todayGovernment-appointed experts have been tasked with preparing the new NLEM to decide on which group of antibiotics should be included and ex...
- Revised NLEM to classify antibiotics by usageNew advice differentiating common antibiotics from those to be used for most serious medical conditions is likely in the revised National L...
- Germ theory: How probiotic products are flying off the shelvesProbiotics gain demand in the new millennium but there is still a lot of grey area around the science of ingesting good bacteria.
- Sitting on a fake CV time bomb: How India Inc is putting in checks to identify discrepancies in resumesAfter a decade of smooth sailing, Sinha was fired in March 2015. Sinha, it was discovered, never had an MBA degree!
Load More
